Structure

Physi-Chem Properties

Molecular Weight:  478.16
Volume:  482.643
LogP:  3.819
LogD:  3.355
LogS:  -3.805
# Rotatable Bonds:  8
TPSA:  114.68
# H-Bond Aceptor:  8
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.427
Synthetic Accessibility Score:  3.467
Fsp3:  0.222
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.979
MDCK Permeability:  1.3426979421637952e-05
Pgp-inhibitor:  0.075
Pgp-substrate:  0.232
Human Intestinal Absorption (HIA):  0.008
20% Bioavailability (F20%):  0.038
30% Bioavailability (F30%):  0.291

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.057
Plasma Protein Binding (PPB):  99.07764434814453%
Volume Distribution (VD):  0.563
Pgp-substrate:  2.52931809425354%

ADMET: Metabolism

CYP1A2-inhibitor:  0.49
CYP1A2-substrate:  0.769
CYP2C19-inhibitor:  0.467
CYP2C19-substrate:  0.064
CYP2C9-inhibitor:  0.713
CYP2C9-substrate:  0.853
CYP2D6-inhibitor:  0.595
CYP2D6-substrate:  0.509
CYP3A4-inhibitor:  0.717
CYP3A4-substrate:  0.388

ADMET: Excretion

Clearance (CL):  11.274
Half-life (T1/2):  0.91

ADMET: Toxicity

hERG Blockers:  0.22
Human Hepatotoxicity (H-HT):  0.165
Drug-inuced Liver Injury (DILI):  0.387
AMES Toxicity:  0.31
Rat Oral Acute Toxicity:  0.102
Maximum Recommended Daily Dose:  0.885
Skin Sensitization:  0.952
Carcinogencity:  0.835
Eye Corrosion:  0.003
Eye Irritation:  0.857
Respiratory Toxicity:  0.373

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC243891

Natural Product ID:  NPC243891
Common Name*:   Agastenol
IUPAC Name:   [(2R,3S,4E)-2-(4-hydroxy-3-methoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methylidene]oxolan-3-yl]methyl 4-hydroxybenzoate
Synonyms:   agastenol
Standard InCHIKey:  NYOJCGUMMQIVQV-HPMYTTEASA-N
Standard InCHI:  InChI=1S/C27H26O8/c1-32-24-12-16(3-9-22(24)29)11-19-14-34-26(18-6-10-23(30)25(13-18)33-2)21(19)15-35-27(31)17-4-7-20(28)8-5-17/h3-13,21,26,28-30H,14-15H2,1-2H3/b19-11-/t21-,26+/m1/s1
SMILES:  COc1cc(ccc1O)/C=C1/CO[C@@H](c2ccc(c(c2)OC)O)[C@@H]1COC(=O)c1ccc(cc1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL464349
PubChem CID:   10073783
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0002279] Benzene and substituted derivatives
        • [CHEMONTID:0000176] Benzoic acids and derivatives
          • [CHEMONTID:0001350] Benzoic acid esters
            • [CHEMONTID:0004701] p-Hydroxybenzoic acid esters
              • [CHEMONTID:0004702] p-Hydroxybenzoic acid alkyl esters

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26351 Agastache rugosa Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[11908994]
NPO26351 Agastache rugosa Species Lamiaceae Eukaryota n.a. root n.a. PMID[1823989]
NPO26351 Agastache rugosa Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[31747281]
NPO26351 Agastache rugosa Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[8594148]
NPO26351 Agastache rugosa Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO26351 Agastache rugosa Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO26351 Agastache rugosa Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT466 Cell Line U-937 Homo sapiens IC50 = 11.4 ug.mL-1 PMID[520099]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC243891 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9931 High Similarity NPC267091
0.9408 High Similarity NPC469889
0.9286 High Similarity NPC45943
0.9267 High Similarity NPC469888
0.9262 High Similarity NPC476434
0.9252 High Similarity NPC472969
0.9236 High Similarity NPC67467
0.9189 High Similarity NPC98809
0.9189 High Similarity NPC476394
0.9156 High Similarity NPC216916
0.9091 High Similarity NPC53889
0.9085 High Similarity NPC226759
0.9038 High Similarity NPC173729
0.9038 High Similarity NPC223006
0.9038 High Similarity NPC272750
0.9038 High Similarity NPC134047
0.9026 High Similarity NPC87317
0.9007 High Similarity NPC75695
0.8994 High Similarity NPC180768
0.898 High Similarity NPC473090
0.898 High Similarity NPC469615
0.8974 High Similarity NPC144557
0.8968 High Similarity NPC476373
0.8961 High Similarity NPC133984
0.8961 High Similarity NPC38779
0.8961 High Similarity NPC114179
0.8961 High Similarity NPC156818
0.8961 High Similarity NPC289322
0.8961 High Similarity NPC160512
0.8961 High Similarity NPC68324
0.8954 High Similarity NPC145425
0.8954 High Similarity NPC203757
0.8947 High Similarity NPC44730
0.8919 High Similarity NPC469683
0.8904 High Similarity NPC100675
0.8904 High Similarity NPC326065
0.8896 High Similarity NPC104983
0.8896 High Similarity NPC471405
0.8896 High Similarity NPC291948
0.8896 High Similarity NPC300845
0.8896 High Similarity NPC88803
0.8896 High Similarity NPC250436
0.8889 High Similarity NPC25127
0.8889 High Similarity NPC191046
0.8889 High Similarity NPC287504
0.8889 High Similarity NPC194095
0.8889 High Similarity NPC90431
0.8889 High Similarity NPC327032
0.8882 High Similarity NPC316539
0.8874 High Similarity NPC473091
0.8868 High Similarity NPC311912
0.8867 High Similarity NPC102934
0.8867 High Similarity NPC252402
0.8859 High Similarity NPC287495
0.8859 High Similarity NPC9370
0.8859 High Similarity NPC30890
0.8854 High Similarity NPC476371
0.8854 High Similarity NPC473445
0.8854 High Similarity NPC42797
0.8854 High Similarity NPC476372
0.8851 High Similarity NPC160378
0.8846 High Similarity NPC24164
0.8839 High Similarity NPC35598
0.8839 High Similarity NPC472860
0.8839 High Similarity NPC143328
0.8839 High Similarity NPC222689
0.8836 High Similarity NPC289690
0.8836 High Similarity NPC288452
0.8831 High Similarity NPC300757
0.8831 High Similarity NPC10205
0.8831 High Similarity NPC180901
0.8828 High Similarity NPC281780
0.8824 High Similarity NPC295646
0.8824 High Similarity NPC131121
0.8824 High Similarity NPC474656
0.8824 High Similarity NPC157898
0.882 High Similarity NPC247964
0.8816 High Similarity NPC300329
0.8812 High Similarity NPC88557
0.8805 High Similarity NPC43065
0.8797 High Similarity NPC100420
0.8797 High Similarity NPC291977
0.8797 High Similarity NPC89131
0.8792 High Similarity NPC223185
0.8774 High Similarity NPC318432
0.8774 High Similarity NPC473275
0.8774 High Similarity NPC470896
0.8759 High Similarity NPC471988
0.8758 High Similarity NPC93498
0.8758 High Similarity NPC151425
0.8758 High Similarity NPC163883
0.8758 High Similarity NPC36130
0.8758 High Similarity NPC134905
0.875 High Similarity NPC259576
0.875 High Similarity NPC261322
0.875 High Similarity NPC135127
0.875 High Similarity NPC67247
0.875 High Similarity NPC221091
0.8742 High Similarity NPC142614
0.8742 High Similarity NPC471788
0.8742 High Similarity NPC1580
0.8734 High Similarity NPC285108
0.8734 High Similarity NPC33298
0.8734 High Similarity NPC246024
0.8733 High Similarity NPC98356
0.8726 High Similarity NPC472962
0.8726 High Similarity NPC24627
0.8726 High Similarity NPC239966
0.8726 High Similarity NPC203020
0.8726 High Similarity NPC472961
0.8725 High Similarity NPC239608
0.8725 High Similarity NPC46161
0.8716 High Similarity NPC253481
0.8716 High Similarity NPC253722
0.8716 High Similarity NPC31751
0.8701 High Similarity NPC19380
0.8701 High Similarity NPC146277
0.8701 High Similarity NPC137813
0.8696 High Similarity NPC266545
0.8696 High Similarity NPC21956
0.8696 High Similarity NPC202428
0.8696 High Similarity NPC216403
0.8696 High Similarity NPC41494
0.8696 High Similarity NPC186100
0.8693 High Similarity NPC62354
0.8684 High Similarity NPC111785
0.8681 High Similarity NPC283823
0.8681 High Similarity NPC159418
0.8679 High Similarity NPC100425
0.8675 High Similarity NPC299090
0.8675 High Similarity NPC283081
0.8675 High Similarity NPC153620
0.8675 High Similarity NPC24257
0.8675 High Similarity NPC229264
0.8675 High Similarity NPC221383
0.8675 High Similarity NPC143892
0.8662 High Similarity NPC160780
0.8662 High Similarity NPC289811
0.8658 High Similarity NPC470811
0.8658 High Similarity NPC273657
0.8658 High Similarity NPC106920
0.8658 High Similarity NPC477697
0.8658 High Similarity NPC477696
0.8654 High Similarity NPC227062
0.8649 High Similarity NPC9218
0.8645 High Similarity NPC62051
0.8642 High Similarity NPC476365
0.8639 High Similarity NPC284409
0.8636 High Similarity NPC478268
0.8636 High Similarity NPC124842
0.8636 High Similarity NPC270268
0.8634 High Similarity NPC177362
0.8634 High Similarity NPC473818
0.863 High Similarity NPC120852
0.8627 High Similarity NPC306343
0.8625 High Similarity NPC475738
0.8621 High Similarity NPC68779
0.8621 High Similarity NPC5310
0.8621 High Similarity NPC4982
0.8621 High Similarity NPC106406
0.8621 High Similarity NPC176814
0.8621 High Similarity NPC300776
0.8618 High Similarity NPC236166
0.8618 High Similarity NPC98009
0.8618 High Similarity NPC142528
0.8616 High Similarity NPC76687
0.8611 High Similarity NPC111888
0.8609 High Similarity NPC213482
0.8608 High Similarity NPC239818
0.8608 High Similarity NPC292415
0.8608 High Similarity NPC289346
0.8608 High Similarity NPC300680
0.8608 High Similarity NPC218471
0.86 High Similarity NPC46880
0.86 High Similarity NPC226738
0.86 High Similarity NPC190587
0.86 High Similarity NPC121573
0.86 High Similarity NPC22176
0.8599 High Similarity NPC1913
0.8599 High Similarity NPC108456
0.8599 High Similarity NPC296044
0.8599 High Similarity NPC167098
0.859 High Similarity NPC131532
0.8589 High Similarity NPC469506
0.8581 High Similarity NPC245615
0.8581 High Similarity NPC299706
0.8581 High Similarity NPC115466
0.8581 High Similarity NPC147379
0.8581 High Similarity NPC65591
0.8581 High Similarity NPC61604
0.8581 High Similarity NPC474784
0.8581 High Similarity NPC178574
0.8581 High Similarity NPC308555
0.8581 High Similarity NPC115203
0.8571 High Similarity NPC118162
0.8571 High Similarity NPC32079
0.8571 High Similarity NPC126206
0.8571 High Similarity NPC83049
0.8571 High Similarity NPC200726
0.8571 High Similarity NPC320471

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC243891 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8896 High Similarity NPD4868 Clinical (unspecified phase)
0.8792 High Similarity NPD6143 Clinical (unspecified phase)
0.8618 High Similarity NPD6980 Clinical (unspecified phase)
0.8462 Intermediate Similarity NPD1934 Approved
0.8411 Intermediate Similarity NPD6190 Approved
0.8405 Intermediate Similarity NPD3818 Discontinued
0.8395 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8395 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8395 Intermediate Similarity NPD6166 Phase 2
0.8344 Intermediate Similarity NPD4628 Phase 3
0.8333 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8313 Intermediate Similarity NPD6234 Discontinued
0.8313 Intermediate Similarity NPD7685 Pre-registration
0.8302 Intermediate Similarity NPD3882 Suspended
0.8291 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8272 Intermediate Similarity NPD6232 Discontinued
0.8253 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8242 Intermediate Similarity NPD5844 Phase 1
0.8239 Intermediate Similarity NPD3817 Phase 2
0.8232 Intermediate Similarity NPD7473 Discontinued
0.8176 Intermediate Similarity NPD2801 Approved
0.8176 Intermediate Similarity NPD230 Phase 1
0.8158 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8113 Intermediate Similarity NPD37 Approved
0.8098 Intermediate Similarity NPD7199 Phase 2
0.8084 Intermediate Similarity NPD7074 Phase 3
0.8075 Intermediate Similarity NPD4965 Approved
0.8075 Intermediate Similarity NPD4966 Approved
0.8075 Intermediate Similarity NPD4967 Phase 2
0.8063 Intermediate Similarity NPD1465 Phase 2
0.8025 Intermediate Similarity NPD7075 Discontinued
0.8024 Intermediate Similarity NPD7054 Approved
0.8014 Intermediate Similarity NPD9494 Approved
0.8 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD4380 Phase 2
0.7977 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7976 Intermediate Similarity NPD7472 Approved
0.7973 Intermediate Similarity NPD3764 Approved
0.7964 Intermediate Similarity NPD7228 Approved
0.7949 Intermediate Similarity NPD1511 Approved
0.7941 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD5494 Approved
0.7908 Intermediate Similarity NPD7266 Discontinued
0.7905 Intermediate Similarity NPD3027 Phase 3
0.7862 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7848 Intermediate Similarity NPD1512 Approved
0.7843 Intermediate Similarity NPD2935 Discontinued
0.784 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD6386 Approved
0.7826 Intermediate Similarity NPD7411 Suspended
0.7826 Intermediate Similarity NPD6385 Approved
0.7824 Intermediate Similarity NPD6797 Phase 2
0.7805 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.78 Intermediate Similarity NPD6233 Phase 2
0.7785 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD6559 Discontinued
0.7778 Intermediate Similarity NPD7251 Discontinued
0.7778 Intermediate Similarity NPD6801 Discontinued
0.7771 Intermediate Similarity NPD8127 Discontinued
0.7733 Intermediate Similarity NPD6798 Discontinued
0.7733 Intermediate Similarity NPD7808 Phase 3
0.773 Intermediate Similarity NPD7819 Suspended
0.7722 Intermediate Similarity NPD6799 Approved
0.7692 Intermediate Similarity NPD9545 Approved
0.7683 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7674 Intermediate Similarity NPD7038 Approved
0.7674 Intermediate Similarity NPD7039 Approved
0.7671 Intermediate Similarity NPD1608 Approved
0.7662 Intermediate Similarity NPD1510 Phase 2
0.7643 Intermediate Similarity NPD4110 Phase 3
0.7643 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD8166 Discontinued
0.7628 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7628 Intermediate Similarity NPD1549 Phase 2
0.7625 Intermediate Similarity NPD6273 Approved
0.7593 Intermediate Similarity NPD3455 Phase 2
0.7593 Intermediate Similarity NPD7458 Discontinued
0.7582 Intermediate Similarity NPD447 Suspended
0.7582 Intermediate Similarity NPD6355 Discontinued
0.7576 Intermediate Similarity NPD5353 Approved
0.7576 Intermediate Similarity NPD5402 Approved
0.7574 Intermediate Similarity NPD5242 Approved
0.7564 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7564 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD2534 Approved
0.7562 Intermediate Similarity NPD2532 Approved
0.7562 Intermediate Similarity NPD2533 Approved
0.7557 Intermediate Similarity NPD8434 Phase 2
0.7546 Intermediate Similarity NPD6599 Discontinued
0.7545 Intermediate Similarity NPD919 Approved
0.7532 Intermediate Similarity NPD3750 Approved
0.7531 Intermediate Similarity NPD1653 Approved
0.753 Intermediate Similarity NPD7768 Phase 2
0.7529 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD1240 Approved
0.7516 Intermediate Similarity NPD1613 Approved
0.7516 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2796 Approved
0.75 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD8312 Approved
0.7486 Intermediate Similarity NPD8313 Approved
0.7485 Intermediate Similarity NPD3749 Approved
0.7485 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD3226 Approved
0.7471 Intermediate Similarity NPD7240 Approved
0.7471 Intermediate Similarity NPD3926 Phase 2
0.7469 Intermediate Similarity NPD5403 Approved
0.7466 Intermediate Similarity NPD17 Approved
0.7456 Intermediate Similarity NPD6959 Discontinued
0.7436 Intermediate Similarity NPD7033 Discontinued
0.7432 Intermediate Similarity NPD9269 Phase 2
0.7421 Intermediate Similarity NPD7003 Approved
0.7419 Intermediate Similarity NPD1607 Approved
0.741 Intermediate Similarity NPD8455 Phase 2
0.7403 Intermediate Similarity NPD943 Approved
0.7399 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD2438 Suspended
0.7389 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7379 Intermediate Similarity NPD5536 Phase 2
0.7368 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD1933 Approved
0.7346 Intermediate Similarity NPD5401 Approved
0.7346 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7345 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7342 Intermediate Similarity NPD2344 Approved
0.7342 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD7440 Discontinued
0.7325 Intermediate Similarity NPD2799 Discontinued
0.732 Intermediate Similarity NPD7095 Approved
0.731 Intermediate Similarity NPD7229 Phase 3
0.7303 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD3620 Phase 2
0.729 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD4060 Phase 1
0.7285 Intermediate Similarity NPD2797 Approved
0.7278 Intermediate Similarity NPD1551 Phase 2
0.7273 Intermediate Similarity NPD3268 Approved
0.7267 Intermediate Similarity NPD2354 Approved
0.7267 Intermediate Similarity NPD3887 Approved
0.7263 Intermediate Similarity NPD8150 Discontinued
0.7255 Intermediate Similarity NPD6832 Phase 2
0.7251 Intermediate Similarity NPD1247 Approved
0.7226 Intermediate Similarity NPD4062 Phase 3
0.7222 Intermediate Similarity NPD5283 Phase 1
0.7219 Intermediate Similarity NPD1283 Approved
0.7215 Intermediate Similarity NPD3748 Approved
0.7215 Intermediate Similarity NPD4308 Phase 3
0.7205 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD228 Approved
0.7202 Intermediate Similarity NPD1006 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD3972 Approved
0.7197 Intermediate Similarity NPD6653 Approved
0.719 Intermediate Similarity NPD2861 Phase 2
0.7186 Intermediate Similarity NPD6873 Phase 2
0.7181 Intermediate Similarity NPD7680 Approved
0.7179 Intermediate Similarity NPD2979 Phase 3
0.7176 Intermediate Similarity NPD6971 Discontinued
0.7171 Intermediate Similarity NPD1203 Approved
0.7162 Intermediate Similarity NPD9268 Approved
0.7161 Intermediate Similarity NPD2313 Discontinued
0.716 Intermediate Similarity NPD2309 Approved
0.7152 Intermediate Similarity NPD920 Approved
0.7152 Intermediate Similarity NPD7097 Phase 1
0.7151 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4908 Phase 1
0.7143 Intermediate Similarity NPD7177 Discontinued
0.7134 Intermediate Similarity NPD3146 Approved
0.7134 Intermediate Similarity NPD3688 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD3705 Approved
0.7126 Intermediate Similarity NPD7028 Phase 2
0.7125 Intermediate Similarity NPD6004 Phase 3
0.7125 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD2346 Discontinued
0.7125 Intermediate Similarity NPD6002 Phase 3
0.7125 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD6005 Phase 3
0.7124 Intermediate Similarity NPD2798 Approved
0.7124 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD1876 Approved
0.7099 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD1481 Phase 2
0.7081 Intermediate Similarity NPD5958 Discontinued
0.7073 Intermediate Similarity NPD4357 Discontinued
0.7063 Intermediate Similarity NPD5406 Approved
0.7063 Intermediate Similarity NPD5404 Approved
0.7063 Intermediate Similarity NPD5405 Approved
0.7063 Intermediate Similarity NPD5408 Approved
0.7059 Intermediate Similarity NPD5977 Approved
0.7059 Intermediate Similarity NPD5978 Approved
0.7051 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD3751 Discontinued
0.7045 Intermediate Similarity NPD2163 Approved
0.7043 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD7549 Discontinued
0.7037 Intermediate Similarity NPD1243 Approved
0.703 Intermediate Similarity NPD642 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data